Vicarious Surgical Inc.
RBOTOTCHealthcare● Active
$0.55
+$0.01(+2.54%)
Market Cap$3558625
P/E Ratio—
52W High$13.746
52W Low$0.27
Vicarious Surgical Inc. (RBOT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RBOT · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$1.03
Est. -$1.20 · +14.2%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
RBOT reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | -$1.15 | — | — | — | — | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | -$1.20 | -$1.03 | +14.2% | — | — | — |
| ▼ Q1 FY2026 | Mar 9, 2026 | -$1.37 | -$1.65 | -20.4% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$2.37 | -$1.91 | +19.4% | — | — | — |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$2.61 | -$2.23 | +14.6% | — | — | — |
| ▲ Q2 FY2025 | May 12, 2025 | -$2.61 | -$2.58 | +1.1% | — | — | — |
| ▲ Q1 FY2025 | Mar 17, 2025 | -$2.69 | -$2.43 | +9.7% | $0.00B | — | — |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$2.61 | -$2.87 | -10.0% | — | — | — |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
-$1.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
-$1.03
EPS Est.
-$1.20
EPS Surpr.
+14.2%
Revenue
—
Q1 FY2026
Mar 9, 2026Miss
EPS Actual
-$1.65
EPS Est.
-$1.37
EPS Surpr.
-20.4%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$1.91
EPS Est.
-$2.37
EPS Surpr.
+19.4%
Revenue
—
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$2.23
EPS Est.
-$2.61
EPS Surpr.
+14.6%
Revenue
—
Q2 FY2025
May 12, 2025Beat
EPS Actual
-$2.58
EPS Est.
-$2.61
EPS Surpr.
+1.1%
Revenue
—
Q1 FY2025
Mar 17, 2025Beat
EPS Actual
-$2.43
EPS Est.
-$2.69
EPS Surpr.
+9.7%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$2.87
EPS Est.
-$2.61
EPS Surpr.
-10.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.67 | $-0.67 | $-0.67 | 1 |
| Q3 FY2027 | $-0.66 | $-0.66 | $-0.66 | 1 |
| Q2 FY2027 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q1 FY2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q4 FY2026 | $-0.61 | $-0.61 | $-0.61 | 1 |
| Q3 FY2026 | $-1.10 | $-1.10 | $-1.10 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +14.2% | $0.55 | $0.50 | -9.09% |
| ▼ Q1 FY2026 | Mar 9, 2026 | -20.4% | $0.27 | $0.37 | +37.41% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +19.4% | $4.57 | $4.12 | -9.85% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +14.6% | $9.20 | $10.35 | +12.50% |
| ▲ Q2 FY2025 | May 12, 2025 | +1.1% | $8.62 | $8.87 | +2.90% |
| ▲ Q1 FY2025 | Mar 17, 2025 | +9.7% | $8.90 | $9.63 | +8.20% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -10.0% | $11.15 | $11.14 | -0.09% |
| ▲ Q3 FY2024 | Aug 12, 2024 | +4.0% | $6.07 | $5.50 | -9.39% |
Q2 FY2026-9.09%
Report Date
Apr 30, 2026
EPS Beat/Miss
+14.2%
Price Before
$0.55
Price After
$0.50
Q1 FY2026+37.41%
Report Date
Mar 9, 2026
EPS Beat/Miss
-20.4%
Price Before
$0.27
Price After
$0.37
Q4 FY2025-9.85%
Report Date
Nov 12, 2025
EPS Beat/Miss
+19.4%
Price Before
$4.57
Price After
$4.12
Q3 FY2025+12.50%
Report Date
Aug 12, 2025
EPS Beat/Miss
+14.6%
Price Before
$9.20
Price After
$10.35
Q2 FY2025+2.90%
Report Date
May 12, 2025
EPS Beat/Miss
+1.1%
Price Before
$8.62
Price After
$8.87
Q1 FY2025+8.20%
Report Date
Mar 17, 2025
EPS Beat/Miss
+9.7%
Price Before
$8.90
Price After
$9.63
Q4 FY2024-0.09%
Report Date
Nov 12, 2024
EPS Beat/Miss
-10.0%
Price Before
$11.15
Price After
$11.14
Q3 FY2024-9.39%
Report Date
Aug 12, 2024
EPS Beat/Miss
+4.0%
Price Before
$6.07
Price After
$5.50
Avg Beat Reaction-0.79%
Avg Miss Reaction+18.66%
Beat Rate6 / 8 quarters
Largest Move+37.41% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RBOT ends December
Vicarious Surgical Inc. (RBOT) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-1.03 — beating the analyst consensus of $-1.20 by +14.2%. The next RBOT earnings date is expected around September 1, 2026.
Each quarter, investors track RBOT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RBOT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RBOT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RBOT earnings · 5 questionsVicarious Surgical Inc.'s next earnings report is expected around September 1, 2026. RBOT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RBOT historically reports after market close (AMC).
RBOT earnings datewhen is RBOT earningsRBOT next earnings datewhen does RBOT report earningsRBOT earnings calendar
▸ Source: FMP · Vicarious Surgical Inc. SEC filings · US GAAP · Vicarious Surgical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026